Literature DB >> 36246817

Are pregnancy-associated hypertensive disorders so sweet?

Costas Thomopoulos1, Ioannis Ilias2.   

Abstract

Worldwide, one in seven pregnancies is complicated by some form of diabetes, with a rising trend. Additionally, hypertension is one of the main causes of morbidity and mortality for both the pregnant woman and the fetus and also contributes to premature birth. In a cohort study of pregnant women with diabetes, which was recently published in this journal, at least 84.5% of the subjects had hypertension. This rate of hypertension might be among the highest reported thus far. In the medical literature, approximately 20% of women with diabetes during pregnancy have various pregnancy-associated hypertensive disorders. Racial/ethnic differences, apparently, were not implicated in this elevated rate of hypertension: Although black and Hispanic women have a twofold higher rate of hypertension in pregnancy compared to white women, 75% of the subjects in the study in question were white. Thus, the impressive finding delivered by this large study, merits additional clarifications. ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Diabetes; Gestational diabetes; Human; Hypertension; Pre-eclampsia; Pregnancy

Year:  2022        PMID: 36246817      PMCID: PMC9561568          DOI: 10.12998/wjcc.v10.i28.10384

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.534


Core Tip: In a recent large study of pregnant women with diabetes, more than 84.5% of the subjects had hypertension, a rate which is fourfold higher than in the literature. Such a finding merits additional clarification.

TO THE EDITOR

We read with interest the paper by Xaverius et al[1] focusing on the association between different phenotypes of diabetic pregnancies and birth outcomes. In this paper, the authors considered, reasonably, gestational or chronic hypertension to be a confounding factor, because hypertension in pregnancy was related to both the predictor and outcome of their investigation. It is striking that most pregnant women with diabetes included in this study had hypertension (with rates ranging from 84.5% to 95.0%)[1]. To the best of our knowledge, this rate of hypertension might be among the highest reported thus far. A tentative explanation could be that racial/ethnic differences were implicated in this elevated rate of hypertension: black and Hispanic women have a twofold higher rate of hypertension in pregnancy compared to white women[2]. Nevertheless, approximately 75% of the population which was included in the study by Xaverius et al[1] were white. In the Control of Hypertension in Pregnancy Study (CHIPS), which included women with gestational or chronic hypertension[3], only 6% had gestational diabetes at enrollment, while in the recent Chronic Hypertension and Pregnancy (CHAP) trial, which included only women with chronic hypertension[4], the reported gestational diabetes rate was 15%. Additionally, in the literature, approximately 20% of women with diabetes during pregnancy have various pregnancy-associated hypertensive disorders[5-7]. Thus, in the study by Xaverius et al[1] the rate of hypertension in pregnancy is fourfold higher than in the literature. This impressive finding, delivered by this large pregnancy cohort[1], merits additional clarifications.
  7 in total

1.  Less-tight versus tight control of hypertension in pregnancy.

Authors:  Laura A Magee; Peter von Dadelszen; Evelyne Rey; Susan Ross; Elizabeth Asztalos; Kellie E Murphy; Jennifer Menzies; Johanna Sanchez; Joel Singer; Amiram Gafni; Andrée Gruslin; Michael Helewa; Eileen Hutton; Shoo K Lee; Terry Lee; Alexander G Logan; Wessel Ganzevoort; Ross Welch; Jim G Thornton; Jean-Marie Moutquin
Journal:  N Engl J Med       Date:  2015-01-29       Impact factor: 91.245

2.  Hypertension in Pregnancy: Diagnosis, Blood Pressure Goals, and Pharmacotherapy: A Scientific Statement From the American Heart Association.

Authors:  Vesna D Garovic; Ralf Dechend; Thomas Easterling; S Ananth Karumanchi; Suzanne McMurtry Baird; Laura A Magee; Sarosh Rana; Jane V Vermunt; Phyllis August
Journal:  Hypertension       Date:  2021-12-15       Impact factor: 9.897

3.  Treatment for Mild Chronic Hypertension during Pregnancy.

Authors:  Alan T Tita; Jeff M Szychowski; Kim Boggess; Lorraine Dugoff; Baha Sibai; Kirsten Lawrence; Brenna L Hughes; Joseph Bell; Kjersti Aagaard; Rodney K Edwards; Kelly Gibson; David M Haas; Lauren Plante; Torri Metz; Brian Casey; Sean Esplin; Sherri Longo; Matthew Hoffman; George R Saade; Kara K Hoppe; Janelle Foroutan; Methodius Tuuli; Michelle Y Owens; Hyagriv N Simhan; Heather Frey; Todd Rosen; Anna Palatnik; Susan Baker; Phyllis August; Uma M Reddy; Wendy Kinzler; Emily Su; Iris Krishna; Nicki Nguyen; Mary E Norton; Daniel Skupski; Yasser Y El-Sayed; Dotum Ogunyemi; Zorina S Galis; Lorie Harper; Namasivayam Ambalavanan; Nancy L Geller; Suzanne Oparil; Gary R Cutter; William W Andrews
Journal:  N Engl J Med       Date:  2022-04-02       Impact factor: 176.079

Review 4.  Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis.

Authors:  Mitsumasa Umesawa; Gen Kobashi
Journal:  Hypertens Res       Date:  2016-09-29       Impact factor: 3.872

Review 5.  Hypertension complicating diabetic pregnancies: pathophysiology, management, and controversies.

Authors:  Shannon D Sullivan; Jason G Umans; Robert Ratner
Journal:  J Clin Hypertens (Greenwich)       Date:  2011-04       Impact factor: 3.738

6.  Maternal Race/Ethnicity, Hypertension, and Risk for Stroke During Delivery Admission.

Authors:  Eliza C Miller; Maria Daniela Zambrano Espinoza; Yongmei Huang; Alexander M Friedman; Amelia K Boehme; Natalie A Bello; Kirsten L Cleary; Jason D Wright; Mary E D'Alton
Journal:  J Am Heart Assoc       Date:  2020-01-24       Impact factor: 5.501

7.  Association of types of diabetes and insulin dependency on birth outcomes.

Authors:  Pamela K Xaverius; Steven W Howard; Deborah Kiel; Jerry E Thurman; Ethan Wankum; Catherine Carter; Clairy Fang; Romi Carriere
Journal:  World J Clin Cases       Date:  2022-03-06       Impact factor: 1.337

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.